-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, EMvTgbSMsOF6+1sCk66ZrmkgpYS23FbEgNl7gqNNJd3HU7wysvOF7Bn2dd4LZcCI 0O0ZmCA7cKcu2TFlGNDFOg== 0000217028-95-000003.txt : 19950608 0000217028-95-000003.hdr.sgml : 19950608 ACCESSION NUMBER: 0000217028-95-000003 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19950125 ITEM INFORMATION: Changes in control of registrant FILED AS OF DATE: 19950131 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: RHONE POULENC RORER INC CENTRAL INDEX KEY: 0000217028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 231699163 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05851 FILM NUMBER: 95504036 BUSINESS ADDRESS: STREET 1: 500 ARCOLA RD STREET 2: P O BOX 1200 CITY: COLLEGEVILLE STATE: PA ZIP: 19426 BUSINESS PHONE: 2154548000 FORMER COMPANY: FORMER CONFORMED NAME: RORER GROUP INC DATE OF NAME CHANGE: 19900731 FORMER COMPANY: FORMER CONFORMED NAME: RORER AMCHEM INC DATE OF NAME CHANGE: 19770604 8-K 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 25, 1995 ----------------------------------------------- Rhone-Poulenc Rorer Inc. -------------------------------------------------- (Exact name of registrant as specified in its charter) Pennsylvania 1-5851 23-1699163 - ----------------------------------------------------------------------------- (State or other juris- (Commission (IRS Employer diction of incorporation) File Number) Identification No.) 500 Arcola Road, Collegeville, PA 19426 ------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (610)454-8000 -------------------------- - ------------------------------------------------------------------------------ (Former name or former address, if changed since last report) Item 5. Other Events --------------------- Rhone-Poulenc Rorer Announces Management Changes, Michel -------------------------------------------------------------------- de Rosen to Become Chief Executive Officer ---------------------------------------------------------------- In a January 25, 1995 press release, the Board of Directors of Rhone- Poulenc Rorer announced that Michel de Rosen, President of RPR, Inc will also become Chief Executive Officer effective April 25, 1995, the date of the Annual Meeting of the Shareholders. Robert Cawthorn, presently Chairman and Chief Executive Officer, will remain RPR's Chairman. Prior to his appointment as RPR's President and Chief Operating Officer in September 1993, Mr. de Rosen served as CEO of the Fibers and Polymers Sector of Rhone-Poulenc SA and had previous experience as head of part of Rhone-Poulenc's pharmaceutical business in France. At the same time, RPR announced two other senior management appointments. John Sedor has been appointed to Executive Vice President, RPR. He will retain his responsibilities as President, Armour Pharmaceuticals, RPR's plasma protein company, and, in addition, will oversee Corporate Human Resources and Business Development. He will continue to report to Mr. de Rosen. Timothy Rothwell will join the company as Executive Vice President, RPR, and President, Pharmaceutical Operations. He will be responsible for RPR's worldwide pharmaceutical business operations, excluding Armour and Dermik. Mr. Rothwell will report to Michel de Rosen. Mr. Rothwell joins RPR from Sandoz Pharmaceuticals Corporation, where he was most recently Senior Vice President, Worldwide Business Development and Licensing, and before that was CEO and President of Sandoz's US Pharmaceutical business. These appointments are effective January 30, 1995. - 2 - SIGNATURES ------------------------------------ Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RHONE-POULENC RORER INC. --------------------------------------- (registrant) Dated: January 26, 1995 By: /s/ PATRICK LANGLOIS ------------------------------------ Patrick Langlois Senior Vice President and Chief Financial Officer - 3 - -----END PRIVACY-ENHANCED MESSAGE-----